OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge to the biopharmaceutical industry. Various strategies have been employed enhance antibody titer, including process parameter optimization, genetic engineering, and the use of perfusion processes. Fine-tuning media composition p